Biocom, the association representing the life science industry of California, issued the following statement regarding the announcement that the Nobel Prize in chemistry was awarded to Jennifer Doudna, Ph.D. of the University of California, Berkeley and Emmanuelle Charpentier, Ph.D. of the Max Planck Unit for the Science of Pathogens for their discovery of the genetic scissors CRISPR/Cas9.
“Since the discovery of CRISPR/Cas9 by Drs. Doudna and Charpentier – a result of resilience, curiosity and unfettered innovation – this genome editing tool has revolutionized the field of genetics,” said Joe Panetta, president and CEO of Biocom. “Dr. Doudna is an important visionary in the Bay Area and beyond, and her recognition speaks to the booming innovation in California’s unparalleled life science industry. Drs. Doudna and Charpentier have cemented themselves as tremendous role models for all women in STEM. Without their demonstrated determination, creativity and exploratory spirit, such game-changing scientific breakthroughs and
IT Deal Desk eliminates the hassle of vetting and securing new technology providers
centrexIT, an information technology (IT) services provider helping businesses thrive through technology, and Biocom, California’s leading life science member association, today announced the launch of IT Deal Desk. The latest platform provides Biocom members with exclusive access to an extensive, vetted partner network and simplifies the task of negotiating and securing agreements on members’ behalf.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201006005918/en/
centrexIT and Biocom launch IT Deal Desk, an IT Platform that eliminates the hassle of vetting and securing new technology providers. (Graphic: Business Wire)
“centrexIT has decades of collective experience operating IT strategy in the life science industry. Currently, roughly 40% of our clients work in the space, so we understand what it takes to support regulated businesses,” says Dylan Natter, CEO of centrexIT. “Our company has been part of the